334 related articles for article (PubMed ID: 23117663)
1. [Concepts in anticoagulant therapy - past, present, and future].
Graf L
Ther Umsch; 2012 Nov; 69(11):611-5. PubMed ID: 23117663
[TBL] [Abstract][Full Text] [Related]
2. [New developments in antithrombotic care].
Wautrecht JC
Rev Med Brux; 2009 Sep; 30(4):392-8. PubMed ID: 19899386
[TBL] [Abstract][Full Text] [Related]
3. Novel oral anticoagulants. Part II: direct thrombin inhibitors.
Mehta RS
Expert Rev Hematol; 2010 Jun; 3(3):351-61. PubMed ID: 21082985
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation beyond direct thrombin and factor Xa inhibitors: indications for targeting the intrinsic pathway?
van Montfoort ML; Meijers JC
Thromb Haemost; 2013 Aug; 110(2):223-32. PubMed ID: 23739841
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological strategies for inhibition of thrombin activity.
Alban S
Curr Pharm Des; 2008; 14(12):1152-75. PubMed ID: 18473863
[TBL] [Abstract][Full Text] [Related]
6. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
7. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
[TBL] [Abstract][Full Text] [Related]
8. In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux.
Samama MM; Mendell J; Guinet C; Le Flem L; Kunitada S
Thromb Res; 2012 Apr; 129(4):e77-82. PubMed ID: 21851967
[TBL] [Abstract][Full Text] [Related]
9. Oral and parenteral anticoagulants: new kids on the block.
Aditya S
J Postgrad Med; 2012; 58(4):275-85. PubMed ID: 23298923
[TBL] [Abstract][Full Text] [Related]
10. Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants?
Papadaki S; Tselepis AD
Angiology; 2019 Nov; 70(10):896-907. PubMed ID: 31010298
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of coagulation factors: advances in antithrombotic therapy.
Bauer KA
Semin Thromb Hemost; 2002 Jun; 28 Suppl 2():15-24. PubMed ID: 12073176
[TBL] [Abstract][Full Text] [Related]
12. Emerging anticoagulants: mechanism of action and future potential.
Klement P; Rak J
Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459
[TBL] [Abstract][Full Text] [Related]
13. Role of current and emerging antithrombotics in thrombosis and cancer.
Mousa SA
Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of action of rivaroxaban--an oral, direct Factor Xa inhibitor--compared with other anticoagulants.
Samama MM
Thromb Res; 2011 Jun; 127(6):497-504. PubMed ID: 20888031
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant drugs: what is new?
Kei A; Florentin M; Elisaf M; Liberopoulos E
Int Angiol; 2011 Aug; 30(4):299-320. PubMed ID: 21747349
[TBL] [Abstract][Full Text] [Related]
16. Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors.
Steffel J; Lüscher TF
J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):616-23. PubMed ID: 19561526
[TBL] [Abstract][Full Text] [Related]
17. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
18. Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change.
Zikria JC; Ansell J
Curr Opin Hematol; 2009 Sep; 16(5):347-56. PubMed ID: 19550318
[TBL] [Abstract][Full Text] [Related]
19. Targeting factor Xa and thrombin: impact on coagulation and beyond.
Esmon CT
Thromb Haemost; 2014 Apr; 111(4):625-33. PubMed ID: 24336942
[TBL] [Abstract][Full Text] [Related]
20. Contemporary Anticoagulation Reversal Focus on Direct Thrombin Inhibitors and Factor Xa Inhibitors.
Mancl EE; Crawford AN; Voils SA
J Pharm Pract; 2013 Feb; 26(1):43-51. PubMed ID: 23160865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
